Top Markets
Coin of the day
IDL Diagnostics AB (publ) IDL Diagnostics AB (publ)

IDL Diagnostics AB (publ)

IDLDX
Peringkat dalam Saham #32452
Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops... Specializing in in vitro diagnostics (IVD), IDL Diagnostics AB (publ) develops and markets diagnostic tests aimed at detecting cancer and bacterial infections within the Swedish market. Its product portfolio includes UBC Rapid, a point-of-care solution for both diagnosing and tracking bladder cancer; AroCell TK 210 ELISA, utilized as a biomarker for identifying tumor cells; and TUBEX TF, an in vitro diagnostic tool for pinpointing acute typhoid fever. Formerly operating as AroCell AB (publ), the company is scheduled to adopt the name IDL Diagnostics AB (publ) in May 2025. Established in 2000, its operations are headquartered in Stockholm, Sweden.
Harga Saham
$0.04367217
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$10.06M
Perubahan (1 hari)
3.99%
Perubahan (1 tahun)
-26.77%
Negara
SE
Perdagangan IDL Diagnostics AB (publ) (IDLDX)

Kategori

Riwayat hasil dividen untuk IDL Diagnostics AB (publ) (IDLDX)
Hasil dividen (TTM) dari IDL Diagnostics AB (publ) (simbol saham: IDLDX) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk IDL Diagnostics AB (publ) (IDLDX) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing